Waylivra

Akcea reducing workforce 10% following Waylivra rejection
Biopharma Dive
Thu, 09/6/18 - 07:26 pm
Akcea Therapeutics
layoffs
Waylivra
FDA rejects Akcea rare-disease drug that uses gene-blocking technology
Stat
Mon, 08/27/18 - 11:00 pm
FDA
Akcea Therapeutics
Waylivra
familial chylomicronemia syndrome
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Mon, 08/13/18 - 11:26 am
TG Therapeutics
Sangamo Therapeutics
Akcea Therapeutics
FDA
Waylivra
umbralisib
SB-913
FDA Advisory Committee Votes in Favor of Waylivra for Treatment of Familial Chylomicronemia Syndrome
CP Wire
Fri, 05/11/18 - 10:09 am
Akcea Therapeutics
Ionis Pharmaceuticals
FDA
advisory panel
Waylivra
Volanesorsen
FCS